Open AccessAbstract CT123: Phase I study of a B cell-based and monocyte-based immunotherapeutic vaccine, BVAC-C, in human papillomavirus type 16- or 18-positive recurrent cervical cancer
Author(s) -
Chel Hun Choi,
Hyun Jin Choi,
JeongWon Lee,
EunSuk Kang,
Duck Cho,
Byung Kwan Park,
YongMan Kim,
DaeYeon Kim,
Hyungseok Seo,
Myung Hwan Park,
Wuhyun Kim,
Ki-Young Choi,
Taegwon Oh,
Chang–Yuil Kang,
ByoungGie Kim
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct123
Subject(s) - medicine , tolerability , adverse effect , cervical cancer , chemotherapy , gastroenterology , oncology , cancer